Publication | Open Access
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
73
Citations
32
References
2023
Year
OncologyPathologyImmune Checkpoint InhibitorHead And Neck CancerCancer TreatmentPhase 2Neck OncologyMedicineRadiation OncologyRecurrent Metastatic Head
| Year | Citations | |
|---|---|---|
Page 1
Page 1